Matrix-Bio Revenue and Competitors
Estimated Revenue & Valuation
- Matrix-Bio's estimated annual revenue is currently $620k per year.
- Matrix-Bio's estimated revenue per employee is $155,000
Employee Data
- Matrix-Bio has 4 Employees.
- Matrix-Bio grew their employee count by 0% last year.
Matrix-Bio's People
| Name | Title | Email/Phone |
|---|
Matrix-Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $7.9M | 51 | 38% | N/A | N/A |
#3 | $13.2M | 85 | 29% | N/A | N/A |
#4 | $2.5M | 16 | 7% | $8.16M | N/A |
#5 | $2.5M | 16 | 0% | N/A | N/A |
#6 | $8.7M | 56 | 14% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $9.6M | 62 | 5% | N/A | N/A |
#9 | $30.8M | 199 | -18% | N/A | N/A |
#10 | $1.9M | 12 | 20% | N/A | N/A |
What Is Matrix-Bio?
Matrix-Bio's goal is to be a leading provider of metabolomics-based testing in the fast-growing molecular diagnostic testing market. The company's first product, VeraMarkerâ„¢ BCR, a blood test for detecting breast cancer and cancer recurrence monitoring, is being commercialized as the first metabolite-based test in the world. Matrix-Bio is currently exploring the commercial feasibility of additional diagnostics tests using its VeraMarker technology platform, including colon, esophageal, liver and pancreatic cancer; for identifying liver cancer in patients with hepatitis C; and for predicting preoperative chemotherapy effectiveness for breast cancer treatment.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Fort Wayne
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 4 | -20% | N/A |
#2 | $0.3M | 4 | 0% | N/A |
#3 | $0.4M | 5 | 0% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.8M | 5 | 0% | N/A |